These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6540782)

  • 41. Carcinoma infection and immune systems of Ehrlich ascites carcinoma-bearing mice treated with structurally similar sulfonium compounds.
    Nakajima K; Nakajima Y
    Biosci Biotechnol Biochem; 2011; 75(4):808-11. PubMed ID: 21512215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.
    Schäfer E; Maurer-Schultze B
    J Cancer Res Clin Oncol; 1987; 113(3):216-22. PubMed ID: 3584212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ionic titanocene complexes: a new type of antitumor agent.
    Köpf-Maier P; Neuse E; Klapötke T; Köpf H
    Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid induction of cleft palate after treatment with titanocene dichloride?
    Köpf-Maier P
    Toxicology; 1985 Oct; 37(1-2):111-6. PubMed ID: 4060162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.
    Lümmen G; Sperling H; Luboldt H; Otto T; Rübben H
    Cancer Chemother Pharmacol; 1998; 42(5):415-7. PubMed ID: 9771957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The anti-tumor effect of bee honey in Ehrlich ascite tumor model of mice is coincided with stimulation of the immune cells.
    Attia WY; Gabry MS; El-Shaikh KA; Othman GA
    Egypt J Immunol; 2008; 15(2):169-83. PubMed ID: 20306700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor properties of organometallic metallocene complexes of tin and germanium.
    Köpf-Maier P; Janiak C; Schumann H
    J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
    Tshuva EY; Miller M
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlorella vulgaris modulates immunomyelopoietic activity and enhances the resistance of tumor-bearing mice.
    Ramos AL; Torello CO; Queiroz ML
    Nutr Cancer; 2010; 62(8):1170-80. PubMed ID: 21058206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influence of immunological factors on the antitumor action of 4-diphenylylglioxal in Ehrlich ascites cancer].
    Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1969; 12(1):57-67. PubMed ID: 5396284
    [No Abstract]   [Full Text] [Related]  

  • 54. Antitumour action of planar, organometallic rhodium(I) complexes.
    Giraldi T; Zassinovich G; Mestroni G
    Chem Biol Interact; 1974 Dec; 9(6):389-94. PubMed ID: 4434566
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
    Shenoy BD; Udupa N; Kamath R; Devi PU
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
    Elo HO; Lumme PO
    Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2314-21. PubMed ID: 3935051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Enhancement of the therapeutic effect and red cell immune function by radix Trichosanthis in mice bearing Ehrlich ascites carcinoma].
    Guo F
    Zhong Xi Yi Jie He Za Zhi; 1989 Jul; 9(7):418-20, 390. PubMed ID: 2791164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves.
    da Silva SL; Figueiredo PM; Yano T
    Eur J Pharmacol; 2007 Dec; 576(1-3):180-8. PubMed ID: 17716654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.